Download PDF
Thromb Haemost 2009; 102(06): 1280-1282
DOI: 10.1160/TH09-03-0144
Letters to the Editor
Schattauer GmbH

Factor XIII Val34Leu polymorphism and ischaemic stroke in patients with patent foramen ovale

Ewa Wypasek
1   Institute of Cardiology, Jagiellonian University School of Medicine, Cracow, Poland
2   John Paul II Hospital, Cracow, Poland
,
Ewa Stepien
1   Institute of Cardiology, Jagiellonian University School of Medicine, Cracow, Poland
2   John Paul II Hospital, Cracow, Poland
,
Monika Pieculewicz
1   Institute of Cardiology, Jagiellonian University School of Medicine, Cracow, Poland
,
Piotr Podolec
1   Institute of Cardiology, Jagiellonian University School of Medicine, Cracow, Poland
,
Anetta Undas
1   Institute of Cardiology, Jagiellonian University School of Medicine, Cracow, Poland
› Author Affiliations>Financial support: This study was supported by the European Union from the European Regional Development Fund and by a grant from Jagiellonian University School of Medicine (to A.U.).
Further Information

Publication History

Received: 18 May 2009

Accepted after minor revision: 16 September 2009

Publication Date:
28 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Guercini F, Acciarresi M, Agnelli G. et al. Cryptogenic stroke: time to determine aetiology. J Thromb Haemost 2008; 06: 549-554.
    CrossrefPubMedGoogle Scholar
  • 2 Botto N, Spadoni I, Giusti S. et al. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke 2007; 38: 2070-2073.
    CrossrefPubMedGoogle Scholar
  • 3 Pezzini A, Del Zotto E, Magoni M. et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke 2003; 04: 28-33.
    PubMedGoogle Scholar
  • 4 de la Red G, Tàssies D, Espinosa G. et al. Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels. Thromb Haemost 2009; 101: 312-316.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Rallidis LS, Politou M, Komporozos C. et al. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years. Thromb Haemost 2008; 99: 1085-1089.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Slowik A, Dziedzic T, Pera J. et al. Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage. Cerebrovasc Dis 2005; 19: 165-170.
    CrossrefPubMedGoogle Scholar
  • 7 Hegele RA. SNP judgments and freedom of association. Arterioscler Thromb Vasc Biol 2002; 22: 1058-61.
    CrossrefPubMedGoogle Scholar
  • 8 Ariëns RA, Philippou H, Nagaswami C. et al. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000; 96: 988-995.
    PubMedGoogle Scholar
  • 9 Lim BC, Ariëns RA, Carter AM. et al. Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet 2003; 361: 1424-1431.
    CrossrefPubMedGoogle Scholar
  • 10 Austin H, Chimowitz MI, Hill HA. et al. Genetics and Stroke in the Young Study Group. Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke 2002; 33: 2762-2768.
    PubMedGoogle Scholar
  • 11 Pezzini A, Grassi M, Zotto ED. et al. Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? Systematic review and meta-analysis. Thromb Haemost 2009; 101: 813-817.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Lalouschek W, Schillinger M, Hsieh K. et al. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke 2005; 36: 1405-1409.
    CrossrefPubMedGoogle Scholar
  • 13 Rosendaal FR, Doggen CJ, Zivelin A. et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-708.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Jood K, Danielson J, Ladenvall C. et al. Fibrinogen gene variation and ischemic stroke. J Thromb Haemost 2008; 06: 897-904.
    CrossrefPubMedGoogle Scholar